Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular docking strategy: Acetyl tributyl citrate as an example
Shujun Huang
The Science of The Total Environment (2023) Vol. 905, pp. 167904-167904
Closed Access | Times Cited: 60
Multi-strain probiotics ameliorate Alzheimer’s-like cognitive impairment and pathological changes through the AKT/GSK-3β pathway in senescence-accelerated mouse prone 8 mice
Qian Xiao-hang, Chen Si-yue, Huidong Tang
Brain Behavior and Immunity (2024) Vol. 119, pp. 14-27
Closed Access | Times Cited: 19
Identification of immune microenvironment subtypes and signature genes for Alzheimer’s disease diagnosis and risk prediction based on explainable machine learning
Yongxing Lai, Peiqiang Lin, Fan Lin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Multi-omics data reveals aberrant gut microbiota-host glycerophospholipid metabolism in association with neuroinflammation in APP/PS1 mice
Xiaohang Qian, Wangxi Hai, Siyue Chen, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 37
Metabolic stress and age drive inflammation and cognitive decline in mice and humans
Sarah E. Elzinga, Kai Guo, Ali Turfah, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Natural killer cells in aging and age-related diseases
Caiyun Qi, Qiang Liu
Neurobiology of Disease (2023) Vol. 183, pp. 106156-106156
Open Access | Times Cited: 17
A review and analysis of key biomarkers in Alzheimer’s disease
Zhihao Zhang, Xiangtao Liu, Suixia Zhang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 7
Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease
Shan He, Junhe Shi, Hua Chai, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26642-e26642
Open Access | Times Cited: 6
Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer’s disease
Miao Zhang, Xiaohang Qian, Jialin Hu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 2, pp. 455-467
Open Access | Times Cited: 11
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis
Clelia Di Salvo, Vanessa D’Antongiovanni, Laura Benvenuti, et al.
Food & Function (2024)
Open Access | Times Cited: 4
Exploring the Kidney-Brain Crosstalk: Biomarkers for Early Detection of Kidney Injury-Related Alzheimer’s Disease
Yawen Cai, Guiqin Huang, Menghui Ren, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 827-846
Open Access
Molecular Mechanisms of Dietary Bioactive Peptides in Treating Alzheimer’s Disease and Mild Cognitive Impairment by Network Pharmacology and Molecular Docking Analysis
Ruirui Li, Jing Zi, Y. Hu, et al.
Rejuvenation Research (2025)
Closed Access
Natural Killer Cells in Alzheimer's Disease: From Foe to Friend
Miloš Kostić, Nikola Živković, Ana Cvetanović, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 7
Closed Access
Potential plasma biomarkers at low altitude for prediction of acute mountain sickness
Haoran Guo, Qi Wang, Tao Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study
Rebecca G. Smith, Ehsan Pishva, Morteza Kouhsar, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 2
A blood-based composite panel that screens Alzheimer’s disease
Yan Wang, Ying Li, Yan Li, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Mechanisms with Network Pharmacology Approach of Ginsenosides in Alzheimer's Disease
Shan He, Junhe Shi, Hua Chai, et al.
(2023)
Closed Access | Times Cited: 1
Astragaloside IV confronts amyloid-beta-induced astrocyte senescence via hsp90aa1
Yan Xia, Rongxiang Zeng, Yajun Cao
Journal of Applied Biomedicine (2024)
Open Access
Identification of altered immune cell types and molecular mechanisms in Alzheimer’s disease progression by single-cell RNA sequencing
Hua Lin, Li Su, Daniel Mao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
A Transcriptomics-Based Machine Learning Model Discriminating Mild Cognitive Impairment and the Prediction of Conversion to Alzheimer’s Disease
Min‐Koo Park, Jinhyun Ahn, Jin‐Muk Lim, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1920-1920
Open Access
Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
Weichu Wu, Yonghai Zhang, Guoyuan Liu, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access
Page 1

Scroll to top